MedPath

Femtosecond Laser for Cataract Surgery

Phase 3
Terminated
Conditions
Cataract
Interventions
Procedure: U/S Surgery and CCC
Device: FS Laser Surgery
Registration Number
NCT02110212
Lead Sponsor
Abbott Medical Optics
Brief Summary

The objective of this study is to evaluate the safety and efficacy the OptiMedica Femtosecond Laser System, also known as the Catalys™ Precision Laser System, to perform two surgical maneuvers used in the treatment of subjects with cataracts. Efficacy will be evaluated by comparisons to the standard surgical procedure of continuous curvilinear capsulorhexis (CCC) and ultrasonic phacoemulsification.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Able and willing to comply with the treatment/follow-up schedule and requirements
  • Able to understand and provide written Informed Consent
  • ETDRS visual acuity equal to or worse than 20/32 (best corrected)
  • Age between 50 and 80 years old
  • Pupil dilates to at least 6 mm
  • Subject able to fixate
  • Grade 1-4 nuclear sclerotic cataract (LOCS III)
  • Axial length between 22 and 26 mm
Exclusion Criteria
  • Pregnant, intending to become pregnant during course of the study, less than 3 months postpartum or less than 6 weeks after completion of breastfeeding
  • Participation in a study of another device or drug within 3 months prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria
  • Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study or for which cataract surgery is contraindicated
  • Anterior chamber depth (anterior corneal surface to anterior capsule margin) less than 2.5 mm via IOL Master (Zeiss).
  • History of prior ocular surgery
  • History of ocular trauma
  • Co-existing ocular disease affecting vision
  • History or current use of alpha-1 antagonist medication (e.g., Flomax)
  • Known sensitivity to planned concomitant medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
U/S Surgery and CCCU/S Surgery and CCCUltrasound (U/S) cataract surgery and continuous curvilinear capsulorhexis (CCC).
FS Laser SurgeryFS Laser SurgeryFor femtosecond laser-assisted cataract surgery (FS Laser Surgery), subjects will receive capsulotomy, lens segmentation and, at investigator discretion, lens softening using the femtosecond laser device.
Primary Outcome Measures
NameTimeMethod
Capsulotomy DimensionDay of Surgery

Capsulotomy size will be measured during surgery for both the experimental and control groups.

Secondary Outcome Measures
NameTimeMethod
Cumulative Dissipated Energy (CDE)Day of Surgery

CDE (the amount of ultrasound energy delivered during phacoemulsification of the crystalline lens) used will be measured during surgery.

Trial Locations

Locations (1)

Laser Center

🇩🇴

Santo Domingo, Dominican Republic

© Copyright 2025. All Rights Reserved by MedPath